Roche headquarters in Basel, Switzerland: looking for new growth areas to compensate for the loss of exclusivity on long-time blockbuster drugs. Photograph: Arnd Wiegmann

Swiss drugmaker Roche is to spend $2.4 billion (€2 billion) buying out remaining shareholders in Foundation Medicine, a US molecular and genomic analy(...)

Basel-based Roche, which will buy US-based Foundation through a combination of outstanding and newly issued shares

Roche will acquire a majority stake in molecular and genomic analysis firm Foundation Medicine for up to $1.18 billion, it said on Monday, in a move t(...)